Effect of dexmedetomidine on swallowing function of patients undergoing awake intubation in oral and maxillofacial surgery

doi:10.19439/j.sjos.2021.02.019

Abstract

Abstract: PURPOSE: To evaluate the sedative effect of dexmedetomidine in awake intubation and its influence on swallowing function. METHODS: Fifty patients with awake intubation in oral and maxillofacial surgery were randomly divided into two groups: dexmedetomidine(DEX) group and midazolam+fentanyl(MF) group. 15 min before intubation, patients in DEX group were intravenously given 50 mL dexmedetomidine(1.0 μg/kg), and others in MF group were intravenously given 50 mL normal saline respectively. 5 min before intubation, 10 mL normal saline was given to DEX group, 0.02 mg/kg midazolam and 2.0 μg/kg fentanyl were given to MF group. HR, MAP, RR, SpO₂, Ramsay sedation score and swallowing time were measured at different time points (before induction-T0, before intubation-T1 and after intubation-T2). SPSS 20.0 software package was used for data analysis. RESULTS: There was no significant difference in HR, RR, MAP, SpO₂ and swallowing time between the two groups at T0 time point(P>0.05). Compared with MF group, HR significantly decreased and swallowing time significantly shortened(P<0.05). RR, MAP, SpO₂ and Ramsay sedation score had no significant difference (P>0.05) in DEX group at T1 time point. Compared with MF group, HR significantly decreased and Ramsay sedation score significantly increased(P<0.05); RR, MAP and SpO₂ had no significant difference (P>0.05) in DEX group at T2 time point. Compared with T0 time, HR significantly decreased and swallowing time significantly prolonged (P<0.05); RR, MAP and SpO₂ had no significant difference(P>0.05) in DEX group at T1 time point. Compared with T1 time, Ramsay sedation score decreased with significant difference(P<0.05) at T2 time point. CONCLUSIONS: Dexmedetomidine can provide good sedative effect for patients with awaking intubation without obvious inhibitory effect on swallowing reflex of patients, improving the safety of intubation.

Key words: Dexmedetomidine, Oral and maxillofacial surgery, Awake intubation, Sedation, Swallowing function

CLC Number:

R782.05

DONG Xiang, LAO Wei, LIU Jin-xing, JI Jun. Effect of dexmedetomidine on swallowing function of patients undergoing awake intubation in oral and maxillofacial surgery[J]. Shanghai Journal of Stomatology, 2021, 30(2): 206-209.

References

[1] Sundman E, Witt H, Sandin R, et al.Pharyngeal function and airway protection during subhypnotic concentrations of propofol, isoflurane, and sevoflurane: volunteers examined by pharyngeal videoradiography and simultaneous manometry[J]. Anesthesiology, 2001, 95(5): 1125-1132.
[2] Sheta SA, Al-Sarheed MA, Abdelhalim AA.Intranasal dexmedetomidine vs midazolam for premedication in children undergoing complete dental rehabilitation: a double-blinded randomized controlled trial[J]. Paediatr Anaesth, 2014, 24(2): 181-189.
[3] 王银模, 吴晓智, 江鹤群, 等. 右美托咪定用于清醒慢诱导气管插管的临床观察[J]. 临床麻醉学杂志, 2011, 27(6): 582-583.
[4] 杨沁岩, 朱歆洁, 陈钰铨. 靶控输注异丙酚抑制吞咽反射的镇静深度[J]. 中华麻醉学杂志, 2012, 32(6): 722-723.
[5] Inaba S, Hashimoto M, Takahashi M, et al.Comparison of BIS and Ramsay score for evaluation of sedation with propofolin ICU[J]. Masui, 2007, 56(1): 57-60.
[6] Nakajoh K, Nakagawa T, Sekizawa K, et al.Relation between incidence of pneumonia and protective reflexes in post-stroke patients with oral or tube feeding[J]. J Intern Med, 2000, 247(1): 39-42.
[7] Drozdz DR, Costa CC, Jesus PR, et al.Pharyngeal swallowing phase and chronic cough[J]. Int Arch Otorhinolaryngol, 2012, 16(4): 502-508.
[8] Hammond CAS, Goldstein LB.Cough and aspiration of food and liquids due to oral-pharyngeal dysphagia: ACCP evidence-based clinical practice guidelines[J]. Chest, 2006, 129(1 Suppl): 154S-168S.
[9] 王如蜜, 李月裳, 张长杰, 等. 多伦多床旁吞咽筛查试验在急性期脑卒中后吞咽障碍筛查中的筛检效果评价[J]. 中国康复医学杂志, 2017, 32(11): 1250-1256.
[10] 张婧, 王拥军, 沈彦. 脑卒中后吞咽困难的7种筛选试验的评价研究[J]. 中国组织工程研究, 2004, 8(1): 7-9.
[11] Bucca CB, Bugiani M, Culla B, et al.Chronic cough and irritable larynx[J]. J Allergy Clin Immunol, 2011, 127(2): 412-419.
[12] 温水群, 邓振兴, 徐秋萍, 等. 改良洼田饮水试验在脑卒中吞咽障碍患者中的研究应用[J]. 中国当代医药, 2018, 25(16): 47-49.
[13] 武文娟, 毕霞, 宋磊, 等. 洼田饮水试验在急性脑卒中后吞咽障碍患者中的应用价值[J]. 上海交通大学学报(医学版), 2016, 36(7): 1049-1053.
[14] 李民, 张利萍, 吴新民. 右美托咪啶在临床麻醉中应用的研究进展[J]. 中国临床药理学杂志, 2007, 23(6): 466-470.
[15] 王丽, 张铁军, 彭伟. 不同镇静药对口腔颌面外科术后留置气管导管患者的镇静作用[J]. 中国口腔颌面外科杂志, 2020, 18(1):57-61.
[16] Chu KS, Wang FY, Hsu HT, et al.The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation[J]. Eur J Anaesthesiol, 2010, 27(1): 36-40.